These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 27307525)

  • 1. Summed and Weighted Summary Scores for the Medsger Disease Severity Scale Compared with the Physician's Global Assessment of Disease Severity in Systemic Sclerosis.
    Harel D; Hudson M; Iliescu A; Baron M; ; Steele R
    J Rheumatol; 2016 Aug; 43(8):1510-8. PubMed ID: 27307525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-item Health Profile and Functional Assessment of Chronic Illness Therapy-Dyspnea short form.
    Hinchcliff M; Beaumont JL; Thavarajah K; Varga J; Chung A; Podlusky S; Carns M; Chang RW; Cella D
    Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1620-8. PubMed ID: 22034123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in skin score in early diffuse cutaneous systemic sclerosis are associated with changes in global disease severity.
    Zheng B; Nevskaya T; Baxter CA; Ramey DR; Pope JE; Baron M;
    Rheumatology (Oxford); 2020 Feb; 59(2):398-406. PubMed ID: 31359048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis.
    Bruni C; Ngcozana T; Braschi F; Pucci T; Piemonte G; Benelli L; Poli M; Suliman YA; Guiducci S; Bellando-Randone S; Balduzzi S; Grotts J; Denton CP; Rasero L; Montecucco C; Furst DE; Matucci-Cerinic M
    J Rheumatol; 2019 Jun; 46(6):603-608. PubMed ID: 30442833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.
    Rannou F; Poiraudeau S; Berezné A; Baubet T; Le-Guern V; Cabane J; Guillevin L; Revel M; Fermanian J; Mouthon L
    Arthritis Rheum; 2007 Feb; 57(1):94-102. PubMed ID: 17266096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Less severe disease in patients with early systemic sclerosis?
    Horimoto AMC; Camargo CZ; Kayser C
    Mod Rheumatol; 2019 Nov; 29(6):977-983. PubMed ID: 30472907
    [No Abstract]   [Full Text] [Related]  

  • 8. Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis.
    Smith V; Riccieri V; Pizzorni C; Decuman S; Deschepper E; Bonroy C; Sulli A; Piette Y; De Keyser F; Cutolo M
    J Rheumatol; 2013 Dec; 40(12):2023-8. PubMed ID: 24128778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index.
    Valentini G; Iudici M; Walker UA; Jaeger VK; Baron M; Carreira P; Czirják L; Denton CP; Distler O; Hachulla E; Herrick AL; Kowal-Bielecka O; Pope J; Müller-Ladner U; Riemekasten G; Avouac J; Frerix M; Jordan S; Minier T; Siegert E; Ong VH; Vettori S; Allanore Y
    Ann Rheum Dis; 2017 Jan; 76(1):270-276. PubMed ID: 27621285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment.
    Berth-Jones J; Grotzinger K; Rainville C; Pham B; Huang J; Daly S; Herdman M; Firth P; Hotchkiss K
    Br J Dermatol; 2006 Oct; 155(4):707-13. PubMed ID: 16965419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary disease severity score for juvenile systemic sclerosis.
    La Torre F; Martini G; Russo R; Katsicas MM; Corona F; Calcagno G; Falcini F; Vittadello F; Zulian F
    Arthritis Rheum; 2012 Dec; 64(12):4143-50. PubMed ID: 22886849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frailty index to measure health status in people with systemic sclerosis.
    Rockwood MR; MacDonald E; Sutton E; Rockwood K; Baron M;
    J Rheumatol; 2014 Apr; 41(4):698-705. PubMed ID: 24584923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI).
    Loh CC; Kim J; Su JC; Daniel BS; Venugopal SS; Rhodes LM; Intong LR; Law MG; Murrell DF
    J Am Acad Dermatol; 2014 Jan; 70(1):89-97.e1-13. PubMed ID: 24355263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric properties of the Swedish version of the Scleroderma Health Assessment Questionnaire and the Cochin Hand Function Scale in patients with systemic sclerosis.
    Hesselstrand R; Nilsson JÅ; Sandqvist G
    Scand J Rheumatol; 2013; 42(4):317-24. PubMed ID: 23442162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Belgian Systemic Sclerosis Cohort: correlations between disease severity scores, cutaneous subsets, and autoantibody profile.
    Vanthuyne M; Smith V; De Langhe E; Van Praet J; Arat S; Depresseux G; Westhovens R; Blockmans D; Badot V; Cogan E; De Keyser F; Houssiau FA
    J Rheumatol; 2012 Nov; 39(11):2127-33. PubMed ID: 22984273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health values of patients with systemic sclerosis.
    Khanna D; Ahmed M; Furst DE; Ginsburg SS; Park GS; Hornung R; Tsevat J
    Arthritis Rheum; 2007 Feb; 57(1):86-93. PubMed ID: 17266070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ).
    Georges C; Chassany O; Mouthon L; Tiev K; Toledano C; Meyer O; Marjanovic Z; Heneggar C; Papo T; Crickx B; Sereni D; Cabane J; Farge D
    Clin Rheumatol; 2005 Feb; 24(1):3-10. PubMed ID: 15674652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of the 2017 EUSTAR activity index in an scleroderma cohort.
    Ross L; Stevens W; Wilson M; Huq M; Strickland G; Walker J; Sahhar J; Ngian GS; Roddy J; Youssef P; Proudman S; Nikpour M
    Clin Rheumatol; 2020 Dec; 39(12):3701-3705. PubMed ID: 32696281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient preference disability questionnaire in systemic sclerosis: a cross-sectional survey.
    Mouthon L; Rannou F; Bérezné A; Pagnoux C; Guilpain P; Goldwasser F; Revel M; Guillevin L; Fermanian J; Poiraudeau S
    Arthritis Rheum; 2008 Jul; 59(7):968-73. PubMed ID: 18576298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of sociodemographic and objectively-assessed disease variables with fatigue in systemic sclerosis: an analysis of 785 Canadian Scleroderma Research Group Registry patients.
    Levis B; Kwakkenbos L; Hudson M; Baron M; Thombs BD;
    Clin Rheumatol; 2017 Feb; 36(2):373-379. PubMed ID: 27943045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.